The transition from childhood to adulthood presents unique challenges in diagnosing and managing ADHD. Most diagnostic tools fail…
Blog
Predicting ADHD trends in 2024: Transforming diagnosis & treatment
In the ever-evolving landscape of ADHD diagnosis and treatment, 2024 promises to continue to bring positive changes. Clinical…
5 core themes to help the roll out of successful healthcare innovations
The process for an ADHD diagnosis can include many steps because of a surge in patients and subjective…
What impact is the ADHD medication shortage having on patients and clinicians?
There is currently a global shortage of three types of ADHD medication following a combination of manufacturing issues…
ADHD Awareness Month: Squashing 4 harmful misconceptions
October is ADHD Awareness Month – a time for us to learn more about the neurodevelopmental disorder and…
Why should I switch to QbTest?
QbTest is a market-leading objective ADHD test, supported by over 35 independent research studies and trusted by clinicians…
Qbtech lands in New Zealand (Te Whatu Ora)
We are delighted to announce that QbCheck will be implemented in Te Whatu Ora Health New Zealand starting…
Simon Mundie: New ADHD podcast series
Qbtech is a provider of market-leading objective ADHD tests, QbTest and QbCheck. Our company was born from a…
Meet Qbtech Clinical Advisor: Penny Lazell
This was my reason for being Penny started her health career as a Nurse, specialising in midwifery and…
ADHD: What’s behind the recent explosion in diagnoses?
Discover New Scientist’s latest article on QbTest and how objective tests are helping improve standards for ADHD assessments….